Global Laparoscopic Gynecological Procedures Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Ambulatory Surgery Centers (ASCs)), By Procedures, By Regional Outlook and Forecast, 2023 - 2030

Global Laparoscopic Gynecological Procedures Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Ambulatory Surgery Centers (ASCs)), By Procedures, By Regional Outlook and Forecast, 2023 - 2030

The Global Laparoscopic Gynecological Procedures Market size is expected to reach $39.4 billion by 2030, rising at a market growth of 6.6% CAGR during the forecast period.

Laparoscopic hysterectomy involves making small incisions through which specialized instruments and a camera are inserted. This minimally invasive approach results in reduced surgical trauma, minimizing blood loss and tissue damage compared to open surgeries. Therefore, the laparoscopic hysterectomy segment captured $10,932.8 million revenue in the market in 2022. Patients undergoing laparoscopic hysterectomy typically experience quicker recovery times and can resume daily activities sooner compared to those undergoing traditional open hysterectomy. These factors will boost the demand in the segment. Some of the factors impacting the market are minimally invasive surgery trend, technological advancements in laparoscopic equipment, and substantial initial setup and maintenance costs.

One of the primary drivers for the adoption of these procedures is the significant reduction in postoperative pain experienced by patients. Compared to traditional open surgeries involving larger incisions and more tissue disruption, laparoscopic procedures use smaller incisions, resulting in less pain during recovery. Laparoscopic gynecological procedures typically allow for shorter hospital stays compared to open surgeries. The minimally invasive nature of these procedures often enables patients to recover faster and return to their normal activities sooner. Additionally, advanced laparoscopic instruments incorporate innovative features such as articulation, ergonomic designs, and improved handling. These enhancements enable surgeons to achieve greater precision in manipulating tissues and performing intricate maneuvers during gynecological procedures. The result is enhanced surgical accuracy and improved outcomes. Improved laparoscopic imaging systems offer high-definition visualizations of the surgical site. These aspects will boost the demand in the market.

However, laparoscopic procedures require specialized instruments designed for minimally invasive surgery. These instruments need to be high quality to ensure precision and safety during surgeries. The initial investment in acquiring these instruments can be substantial, impacting the financial feasibility of healthcare facilities, particularly those with limited budgets. Laparoscopic surgeries rely on advanced imaging systems to provide clear and detailed visuals of the surgical site. These aspects will lead to decreased demand in the market.

In the early stages of the pandemic, many healthcare facilities globally faced the need to prioritize resources for COVID-19 patients. As a result, elective surgeries, including certain laparoscopic gynecological procedures, were postponed or canceled to conserve healthcare resources and reduce the risk of virus transmission in healthcare settings. The laparoscopic procedures market relies on a global supply chain for surgical instruments and equipment. Supply chain disruptions resulting from lockdowns, travel restrictions, and manufacturing difficulties caused shortages of particular laparoscopic instruments, negatively impacting the accessibility of these instruments for gynecological surgeries.

End-Use Outlook

On the basis of end-use, the market is divided into hospitals, clinics, and ambulatory surgery centers (ASCs). In 2022, the ambulatory surgery centers (ASCs) segment witnessed a substantial revenue share in the market. Patients often prefer the convenience of ASCs for minor surgical procedures. The utilization of laparoscopic gynecological surgeries in an ambulatory environment enables patients to return home the same day, minimizing the inconvenience to their daily schedules and diminishing the necessity for overnight hospitalization.

Procedures Outlook

Based on procedures, the market is segmented into laparoscopic hysterectomy, laparoscopic myomectomy, laparoscopic colpopexy, laparoscopic endometrial excision, laparoscopic adnexal, and laparoscopic diagnostic procedures. The laparoscopic colpopexy segment procured a promising growth rate in the market in 2022. Laparoscopic procedures, including colpopexy, benefit from high-resolution imaging systems that provide surgeons with detailed views of pelvic anatomy. This enhanced visibility allows for the precise placement of mesh or other supportive materials during the procedure. These factors will help in the expansion of the segment.

Regional Outlook

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America is a hub for technological innovation in healthcare. The region witnesses continuous advancements in laparoscopic instruments, imaging technologies, and robotic-assisted surgical systems. Surgeons in North America have access to cutting-edge equipment, contributing to the increased adoption of laparoscopic techniques. As a result, the segment will grow rapidly in the coming years.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Karl Kaps GmbH & Co. KG, Johnson & Johnson, Olympus Corporation, ConMed Corporation, B. Braun Melsungen AG, Richard Wolf GmbH, Intuitive Surgical, Inc., and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Recent Strategy Deployed in the Laparoscopic Gynecological Procedures Market

Dec-2023: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. completed the acquisition of DiaSys Diagnostic Systems GmbH, a leading specialist in the development of diagnostic system solutions. Through this acquisition, Shenzhen Mindray enhanced its position in the overseas supply chain platform. Additionally, the acquisition assisted in strengthening the In-vitro diagnostics products.

Nov-2023: Ethicon, Inc., a subsidiary of Johnson & Johnson, launched the Ethicon Laparoscopic Skills Training Platform, an AI-powered Surgical Simulation Platform. The new product offers a portable digital learning experience to assist in skill development among surgeons. Additionally, the new product provides artificial intelligence (AI) and augmented reality (AR)-powered training.

Jun-2023: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. formed a partnership with Edwards Lifesciences Corporation, an American medical technology company. Under this partnership, the FloTrac sensor for hemodynamic monitoring from Edwards Lifesciences was integrated with the BeneVision N series patient monitors from Mindray Bio-Medical. Additionally, the partnership assisted in providing comprehensive hemodynamic monitoring solutions to meet acute care needs in a variety of clinical situations.

Dec-2022: Olympus Corporation completed the acquisition of Odin Vision Ltd., a Cloud AI endoscopy company. Through this acquisition, Olympus strengthened its digital strategy to improve patient care. Additionally, Olympus brought about transformations in its procedural and clinical workflows.

Dec-2022: Johnson & Johnson completed the acquisition of Abiomed, Inc., a medical device technology company. Through this acquisition, Johnson & Johnson strengthened its position in the cardiovascular market. Additionally, the acquisition helped add heart recovery solutions to its Biosense Webster electrophysiology business segment.

Sep-2022: Olympus Corporation launched the THUNDERBEAT Open Fine Jaw Type X surgical energy devices to enhance its portfolio of hybrid energy devices. The new product has the features of a thermal shield and helps to support safer procedures. Additionally, the new product helps facilitate open surgery.

Sep-2022: Olympus Corporation introduced the VISERA ELITE III, a surgical visualization platform. The new product provides several imaging functions integrated into a single system. Additionally, the new product helps healthcare professionals carry out several endoscopic procedures in a variety of medical fields.

Sep-2022: B. Braun Melsungen AG completed the acquisition of the Clik-FIX catheter securement device product portfolio of Starboard Medical, Inc., a fully integrated medical device company. Through this acquisition, B. Braun enhanced its products and programs. Additionally, the acquisition helped to improve patient experience through peripheral intravenous (IV) therapy.

May-2022: Medtronic PLC completed the acquisition of Intersect ENT, Inc., a health care equipment company. Through this acquisition, Medtronic incorporated the PROPEL and SINUVA product portfolios. Additionally, the acquisition assisted in enhancing its ENT product portfolio.

Apr-2022: Ethicon, Inc., a subsidiary of Johnson & Johnson MedTech Companies, introduced the ENSEAL X1 Straight Jaw Tissue Sealer. The new product consists of a longer jaw and a longer cut length to capture more tissues per bite. Additionally, the new product assists in thoracic and general laparoscopic surgical procedures.

Jun-2021: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. released the Nuewa I9, a cart-based ultrasound system and tailored solution for Obstetrics and Gynaecology (OB/GYN). The new product has the features of a foldable height and a compact body, making it portable across departments. Additionally, the new product increases scanning capacity and improves imaging quality through advanced technologies.

Scope of the Study

Market Segments covered in the Report:

By End-use

• Hospitals
• Clinics
• Ambulatory Surgery Centers (ASCs)

By Procedures

• Laparoscopic Hysterectomy
• Laparoscopic Myomectomy
• Laparoscopic Diagnostic Procedures
• Laparoscopic Colpopexy
• Laparoscopic Endometrial Excision
• Laparoscopic Adnexal

By Geography

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific
• LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• Medtronic PLC
• Stryker Corporation
• Karl Kaps GmbH & Co. KG
• Johnson & Johnson
• Olympus Corporation
• ConMed Corporation
• B. Braun Melsungen AG
• Richard Wolf GmbH
• Intuitive Surgical, Inc.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free